EXEL vs JAZZ
Exelixis vs Jazz Pharmaceuticals — AI-powered side-by-side comparison
| Metric | EXEL | JAZZ |
|---|---|---|
| AI Score | 59 | 53 |
| Price | $55.91 | — |
| P/E Ratio | 17.92× | 603.73× |
| ROE | 0.4% | -0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 1.0% | 0.8% |
| Debt / Equity | 0.09× | 1.20× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 57.2 | 66.1 |
| Beta | 0.424 | 0.324 |
| Expected Upside | — | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
EXEL Full Analysis
JAZZ Full Analysis